Literature DB >> 3948156

Inactivation of O6-methylguanine-DNA methyltransferase and sensitization of human tumor cells to killing by chloroethylnitrosourea by O6-methylguanine as a free base.

D B Yarosh, S Hurst-Calderone, M A Babich, R S Day.   

Abstract

Human fibroblasts and tumor cells with constitutive levels of the DNA repair protein O6-methylguanine-DNA methyltransferase were incubated with mM concentrations of the free base O6-methylguanine for up to 24 h. This treatment depleted the cells of their transferase activity, and sensitized the cells to killing by the antineoplastic drug 1-[2-chloroethyl]-1-nitrosourea. Cells constitutively lacking the methyltransferase were not sensitized to cell killing. Cell free extracts incubated with O6-methylguanine also lost methyltransferase activity. Other alkylpurines, such as O6-methylguanosine, S6-methylthioguanine, O6-ethylguanine, and 3-methyladenine, did not have this effect on extracts of human tumor cells, while O6-methylguanosine and O6-methylguanine inactivated purified methyltransferase from Escherichia coli. The data suggest that the free base O6-methylguanine is probably a substrate for the methyltransferase. Calculation of the second order rate constants for free base versus O6-methylguanine in DNA, and experiments in which the free base was mixed with DNA containing O6-methylguanine before reaction with methyltransferase, indicated that the base in DNA is about 4 X 10(7) better as a substrate than is the free base. These results demonstrate that DNA repair capacity of tumor cells can be diminished without DNA damage, and suggest a method for increasing the efficiency of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948156

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Direct reversal of DNA alkylation damage.

Authors:  Yukiko Mishina; Erica M Duguid; Chuan He
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

2.  Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.

Authors:  M E Dolan; G L Larkin; H F English; A E Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Drug resistance in brain tumors.

Authors:  L G Feun; N Savaraj; H J Landy
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cells.

Authors:  W Dempke; P Nehls; U Wandl; D Soll; C G Schmidt; R Osieka
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  R B Mitchell; M E Dolan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.

Authors:  R Bianchi; L Citti; R Beghetti; L Romani; M D'Incalci; P Puccetti; M C Fioretti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  6-Methylguanine and 6-methylguanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line but not in other xeroderma pigmentosum and normal human fibroblast strains after treatment with 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea.

Authors:  H W Thielmann; L Edler; N Müller; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.

Authors:  H Frischer; E J Kennedy; R Chigurupati; M Sivarajan
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

10.  Sequential therapy with dacarbazine and carmustine: a phase I study.

Authors:  R B Mitchell; M E Dolan; L Janisch; N J Vogelzang; M J Ratain; R L Schilsky
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.